Pulmonary Disease
New Pulmonary Disease Research from University of Marburg Discussed
Published in Drug Week, August 12th, 2011
2011 AUG 12 -- Data detailed in "NVA237, a long-acting muscarinic antagonist, as an emerging therapy for chronic obstructive pulmonary disease" have been presented. According to the authors of recent research from Marburg, Germany, "Bronchodilation with a long-acting muscarinic antagonist (LAMA) or long-acting ß(2)-agonist is central to the management of chronic obstructive pulmonary disease (COPD). Tiotropium, the first LAMA available for use in COPD, has been shown to be an effective bronchodilator and is generally safe and well tolerated."
"However, tiotropium has limitations that include a high incidence of dry mouth, slow onset of action and, in...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
Source: Drug Week (2011-08-12)
More Articles from Drug Week
- Research and Markets
ADMET for Medicinal Chemists: A Practical Guide - Diazepam Therapy
Data from National Forensic Service Advance Knowledge in Diazepam Therapy - Depression
Data from University of Chicago Provide New Insights into Depression - Amino Acids
Data on Amino Acids Discussed by Researchers at University of Connecticut - Immunotherapy
Findings from John Radcliffe Hospital Broaden Understanding of Immunotherapy - Paracetamol Therapy
Findings in Paracetamol Therapy Reported from University of London - More from this issue of Drug Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
